SoFi Technologies, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
SOFI$16.37-2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In Thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities | ||
| Net income | $307,771 | $166,192 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Share-based compensation expense | 193,481 | 179,785 |
| Depreciation and amortization | 171,271 | 149,953 |
| Deferred debt issuance and discount expense | 8,367 | 10,821 |
| Gain on extinguishment of convertible debt | — | (62,517) |
| Provision for credit losses | 24,912 | 24,835 |
| Deferred income taxes | 26,558 | (2,934) |
| Fair value changes in loans held for investment | (270,698) | (149,474) |
| Fair value changes in securitization investments | (1,582) | (3,311) |
| Other | 9,396 | 1,727 |
| Changes in loans held for sale, net | (3,982,094) | (1,959,781) |
| Changes in accrued interest on loans | (20,838) | (6,164) |
| Changes in loans previously classified as held for sale, net | 673,997 | 983,783 |
| Changes in servicing assets | (41,397) | (115,658) |
| Changes in other assets | (21,215) | (166,555) |
| Changes in other liabilities | 170,791 | 29,594 |
| Net cash used in operating activities | $(2,751,280) | $(919,704) |
| Investing activities | ||
| Purchases of property, equipment and software | $(176,047) | $(112,002) |
| Capitalized software development costs | (7,351) | (7,384) |
| Purchases of available-for-sale investments | (1,124,421) | (1,659,296) |
| Proceeds from sales of available-for-sale investments | 249,488 | 164,623 |
| Proceeds from maturities and paydowns of available-for-sale investments | 339,013 | 616,451 |
| Purchases of loans held for investment | (1,439,681) | — |
| Proceeds from sales of loans held for investment | 392,607 | 434,483 |
| Other changes in loans held for investment, net | (2,859,336) | (3,029,395) |
| Proceeds from securitization investments | 49,406 | 69,455 |
| Proceeds from non-securitization investments | 16,334 | 3,579 |
| Purchases of non-securitization investments | (62,167) | (20,620) |
| Net cash used in investing activities | $(4,622,155) | $(3,540,106) |
Condensed Consolidated Statements of Cash Flows (Continued)
(In Thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Financing activities | ||
| Net change in deposits | $7,101,294 | $5,654,019 |
| Proceeds from issuance of common stock | 1,700,345 | — |
| Payment of common stock issuance costs | (1,620) | — |
| Net change in debt facilities | (359,368) | (1,906,888) |
| Proceeds from other debt issuances | — | 845,250 |
| Repayment of other debt | (25,058) | (340,104) |
| Payment of debt issuance costs | (2,006) | (5,895) |
| Purchase of capped calls | — | (90,649) |
| Unwind of capped calls | — | 10,180 |
| Taxes paid related to net share settlement of share-based awards | (19,849) | (12,641) |
| Proceeds from stock option exercises | 6,647 | 770 |
| Proceeds from issuance of common stock under the ESPP | 11,764 | — |
| Payment of redeemable preferred stock dividends | — | (16,503) |
| Redemption of Series 1 preferred stock | — | (323,400) |
| Finance lease principal payments | (567) | (396) |
| Net cash provided by financing activities | $8,411,582 | $3,813,743 |
| Effect of exchange rates on cash and cash equivalents | (1,060) | 248 |
| Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | $1,037,087 | $(645,819) |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 2,709,360 | 3,615,578 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | $3,746,447 | $2,969,759 |
| Reconciliation to amounts on condensed consolidated balance sheets (as of period end) | ||
| Cash and cash equivalents | $3,246,351 | $2,354,965 |
| Restricted cash and restricted cash equivalents | 500,096 | 614,794 |
| Total cash, cash equivalents, restricted cash and restricted cash equivalents | $3,746,447 | $2,969,759 |
| Supplemental non-cash investing and financing activities | ||
| Deposits credited but not yet received in cash | $337,215 | $133,104 |
| Share-based compensation capitalized related to internally-developed software | 38,376 | 29,297 |
| Extinguishment of convertible notes by issuance of common stock | — | 677,147 |
| Available-for-sale securities sold but unpaid | — | 21,266 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.